Showing results (421-430 of 454) with videos related to

Sort By:
Pageof 46
Cell Reports|October 23, 2021
ROR and RYK extracellular region structures suggest that receptor tyrosine kinases have distinct WNT-recognition modesFumin Shi, Jeannine M Mendrola, Joshua B Sheetz, et al.
Brain Research|February 4, 2019
Dystrophin is required for normal synaptic gain in the Drosophila olfactory circuitSalinee Jantrapirom, De-Shou Cao, Jing W Wang, et al.
Blood Advances|October 29, 2024
Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomesYannis K Valtis, Sean Devlin, Roni Shouval, et al.
Haematologica|September 5, 2024
Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experienceGiulio Cassanello, Esther Drill, Alfredo Rivas-Delgado, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 16, 2014
Incidence and severity of pancreatogenic diabetes after pancreatic resectionRichard A Burkhart, Susan M Gerber, Renee M Tholey, et al.
Plos One|March 21, 2018
Large-scale impacts of sea star wasting disease (SSWD) on intertidal sea stars and implications for recoveryC Melissa Miner, Jennifer L Burnaford, Richard F Ambrose, et al.
NPJ Genomic Medicine|April 15, 2020
ATP7B variant c.1934T > G p.Met645Arg causes Wilson disease by promoting exon 6 skippingDaniele Merico, Carl Spickett, Matthew O'Hara, et al.
Transplantation and Cellular Therapy|July 7, 2024
Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With LymphomaRachel Lorenc, Roni Shouval, Jessica R Flynn, et al.
Blood Cancer Discovery|December 12, 2024
Dynamics of Immune Reconstitution and Impact on Outcomes across CAR-T Cell Products in Large B-cell LymphomaDanny Luan, Susan DeWolf, Teng Fei, et al.
Pageof 46